TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.

• Príomhchruthaitheoirí: Roberto Rodrigues Ferreira (Údar), Rayane da Silva Abreu (Údar), Glaucia Vilar-Pereira (Údar), Wim Degrave (Údar), Marcelo Meuser-Batista (Údar), Nilma Valéria Caldeira Ferreira (Údar), Otacílio da Cruz Moreira (Údar), Natália Lins da Silva Gomes (Údar), Elen Mello de Souza (Údar), Isalira P Ramos (Údar), Sabine Bailly (Údar), Jean-Jacques Feige (Údar), Joseli Lannes-Vieira (Údar), Tania C de Araújo-Jorge (Údar), Mariana Caldas Waghabi (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Public Library of Science (PLoS), 2019-07-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

TGF-β involvement in Chagas disease cardiomyopathy has been clearly demonstrated. The TGF-β signaling pathway is activated in the cardiac tissue of chronic phase patients and is associated with an increase in extracellular matrix protein expression. The aim of this study was to investigate the effec...